Detailed answers about JONADO PHARMACEUTICAL SERVICES LIMITED, including incorporation, status, business activity, and accounts information.
When was JONADO PHARMACEUTICAL SERVICES LIMITED founded?
JONADO PHARMACEUTICAL SERVICES LIMITED was officially incorporated on 16 April 2025 and is registered under company number 16392864. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is JONADO PHARMACEUTICAL SERVICES LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of JONADO PHARMACEUTICAL SERVICES LIMITED?
JONADO PHARMACEUTICAL SERVICES LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does JONADO PHARMACEUTICAL SERVICES LIMITED do?
JONADO PHARMACEUTICAL SERVICES LIMITED operates in the following sectors: 86210 - General medical practice activities, 86900 - Other human health activities. These SIC codes provide insight into the company's business activities and industry focus.
What is JONADO PHARMACEUTICAL SERVICES LIMITED's registered address?
The registered office address of JONADO PHARMACEUTICAL SERVICES LIMITED is 104 40 WINDMILL STREET, BIRMINGHAM, ENGLAND, B1 1GA. This is the official address filed with Companies House for legal and statutory correspondence.
Is JONADO PHARMACEUTICAL SERVICES LIMITED financially stable?
Financial accounts for JONADO PHARMACEUTICAL SERVICES LIMITED are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.